521 related articles for article (PubMed ID: 29219081)
1. Whole genome analysis of CRISPR Cas9 sgRNA off-target homologies via an efficient computational algorithm.
Zhou H; Zhou M; Li D; Manthey J; Lioutikova E; Wang H; Zeng X
BMC Genomics; 2017 Nov; 18(Suppl 9):826. PubMed ID: 29219081
[TBL] [Abstract][Full Text] [Related]
2. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
Haeussler M; Concordet JP
J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
[TBL] [Abstract][Full Text] [Related]
3. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
[TBL] [Abstract][Full Text] [Related]
4. [sgRNA design for the CRISPR/Cas9 system and evaluation of its off-target effects].
Xie SS; Zhang Y; Zhang LS; Li GL; Zhao CZ; Ni P; Zhao SH
Yi Chuan; 2015 Nov; 37(11):1125-36. PubMed ID: 26582526
[TBL] [Abstract][Full Text] [Related]
5. Selection of highly efficient sgRNAs for CRISPR/Cas9-based plant genome editing.
Liang G; Zhang H; Lou D; Yu D
Sci Rep; 2016 Feb; 6():21451. PubMed ID: 26891616
[TBL] [Abstract][Full Text] [Related]
6. Potential high-frequency off-target mutagenesis induced by CRISPR/Cas9 in Arabidopsis and its prevention.
Zhang Q; Xing HL; Wang ZP; Zhang HY; Yang F; Wang XC; Chen QJ
Plant Mol Biol; 2018 Mar; 96(4-5):445-456. PubMed ID: 29476306
[TBL] [Abstract][Full Text] [Related]
7. sgRNAcas9: a software package for designing CRISPR sgRNA and evaluating potential off-target cleavage sites.
Xie S; Shen B; Zhang C; Huang X; Zhang Y
PLoS One; 2014; 9(6):e100448. PubMed ID: 24956386
[TBL] [Abstract][Full Text] [Related]
8. sgRNA Scorer 2.0: A Species-Independent Model To Predict CRISPR/Cas9 Activity.
Chari R; Yeo NC; Chavez A; Church GM
ACS Synth Biol; 2017 May; 6(5):902-904. PubMed ID: 28146356
[TBL] [Abstract][Full Text] [Related]
9. SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.
Vemuri S; Srivastava R; Mir Q; Hashemikhabir S; Dong XC; Janga SC
Methods; 2020 Jun; 178():104-113. PubMed ID: 31494246
[TBL] [Abstract][Full Text] [Related]
10. Generalizable sgRNA design for improved CRISPR/Cas9 editing efficiency.
Hiranniramol K; Chen Y; Liu W; Wang X
Bioinformatics; 2020 May; 36(9):2684-2689. PubMed ID: 31971562
[TBL] [Abstract][Full Text] [Related]
11. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
Graf R; Li X; Chu VT; Rajewsky K
Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
[TBL] [Abstract][Full Text] [Related]
12. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.
Doench JG; Fusi N; Sullender M; Hegde M; Vaimberg EW; Donovan KF; Smith I; Tothova Z; Wilen C; Orchard R; Virgin HW; Listgarten J; Root DE
Nat Biotechnol; 2016 Feb; 34(2):184-191. PubMed ID: 26780180
[TBL] [Abstract][Full Text] [Related]
13. CRISPR multitargeter: a web tool to find common and unique CRISPR single guide RNA targets in a set of similar sequences.
Prykhozhij SV; Rajan V; Gaston D; Berman JN
PLoS One; 2015; 10(3):e0119372. PubMed ID: 25742428
[TBL] [Abstract][Full Text] [Related]
14. Optimizing sgRNA length to improve target specificity and efficiency for the GGTA1 gene using the CRISPR/Cas9 gene editing system.
Matson AW; Hosny N; Swanson ZA; Hering BJ; Burlak C
PLoS One; 2019; 14(12):e0226107. PubMed ID: 31821359
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of the CRISPR-Cas9 effector complex assembly and the role of 3'-terminal segment of guide RNA.
Mekler V; Minakhin L; Semenova E; Kuznedelov K; Severinov K
Nucleic Acids Res; 2016 Apr; 44(6):2837-45. PubMed ID: 26945042
[TBL] [Abstract][Full Text] [Related]
16. Superior Fidelity and Distinct Editing Outcomes of SaCas9 Compared with SpCas9 in Genome Editing.
Yang ZX; Fu YW; Zhao JJ; Zhang F; Li SA; Zhao M; Wen W; Zhang L; Cheng T; Zhang JP; Zhang XB
Genomics Proteomics Bioinformatics; 2023 Dec; 21(6):1206-1220. PubMed ID: 36549468
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CRISPR/Cas9 site-specific function and validation of sgRNA sequence by a Cas9/sgRNA-assisted reverse PCR technique.
Zhang B; Zhou J; Li M; Wei Y; Wang J; Wang Y; Shi P; Li X; Huang Z; Tang H; Song Z
Anal Bioanal Chem; 2021 Apr; 413(9):2447-2456. PubMed ID: 33661348
[TBL] [Abstract][Full Text] [Related]
18. Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing.
Kelley ML; Strezoska Ž; He K; Vermeulen A; Smith Av
J Biotechnol; 2016 Sep; 233():74-83. PubMed ID: 27374403
[TBL] [Abstract][Full Text] [Related]
19. Points of View on the Tools for Genome/Gene Editing.
Chuang CK; Lin WM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576035
[TBL] [Abstract][Full Text] [Related]
20. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
